SFX by Ex Libris Inc.

Title:	Dissecting the genomic complexity underlying medulloblastoma
Source:	Nature [0028-0836] Jones, D T yr:2012

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hawkins, William D. "Subgroup-specific structural variation across 1,000 medulloblastoma genomes." Nature 488.7409 (2012): 49-56.
description	2.	Pugh, Trevor J. "Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations." Nature 488.7409 (2012): 106-110.
description	3.	Northcott, Paul A. "Medulloblastomics: the end of the beginning." Nature Reviews. Cancer 12.12 (2012): 818-834.
description	4.	Taylor, Michael D. "Molecular subgroups of medulloblastoma: the current consensus." Acta neuropathologica 123.4 (2011): 465-72.
description	5.	Marino, S. "Cerebellar granule cells: Insights into proliferation, differentiation, and role in medulloblastoma pathogenesis." The international journal of biochemistry & cell biology 41.3 (2009): 435-445.
description	6.	Gilbertson, R. "Novel mutations target distinct subgroups of medulloblastoma." Nature 488.7409 (2012): 43-48.
description	7.	Northcott, Paul A. "Molecular subgroups of medulloblastoma." Expert review of neurotherapeutics 12.7 (2012): 871-884.
description	8.	Wu, X. "Clonal selection drives genetic divergence of metastatic medulloblastoma." Nature 482.7386 (2012): 529-533.
description	9.	Wilson, Richard K. "Chromothripsis and human disease: piecing together the shattering process." Cell 148.1-2 (2012): 29-32.
description	10.	Clevers, H. "The cancer stem cell: premises, promises and challenges." Nature medicine 17.3 (2011): 313-319.
description	11.	Northcott, Paul A. "The clinical implications of medulloblastoma subgroups." Nature reviews. Neurology 8.6 (2012): 340-351.
description	12.	DeAngelis, Lisa M M. "Chemotherapy for Brain Tumors - A New Beginning." The New England journal of medicine 352.10 (2005): 1036-1038.
description	13.	Pugh, Trevor J. "The genetic landscape of high-risk neuroblastoma." Nature Genetics 45.3 (2013): 279-284.
description	14.	Kool, M. "Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas." Acta neuropathologica 123.4 (2012): 473-84.
description	15.	BENIGNI, R. "Exploring In Vitro/In Vivo Correlation: Lessons Learned from Analyzing Phase I Results of the US EPA's ToxCast Project." Environmental carcinogenesis & ecotoxicology reviews 28.4 (2010): 272-286.
description	16.	Eberhart, Charles G. "Molecular diagnostics in embryonal brain tumors." Brain pathology 21.1 (2011): 96-104.
description	17.	Jepsen, K. "Combinatorial roles of the nuclear receptor corepressor in transcription and development." Cell 102.6 (2000): 753-763.
description	18.	Albright, A. "Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group." Neurosurgery online 38.2 (1996): 265-71.
description	19.	Cho, Y. "Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome." Journal of clinical oncology 29.11 (2010): 1424-1430.
description	20.	Pizer, B. "The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials." British Journal of Neurosurgery 23.4 (2009): 364-375.